ABRCMS Poster E-130: TP53 mutation type

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/50

encourage image

There's no tags or description

Looks like no tags are added yet.

51 Terms

1
New cards

Hypothesis (one line)

Mutation type predicts how much cancer risk, and which cancer

2
New cards

The gap

Past studies disagreed on which mutation type is worse; none compared types in a large directly tested cohort

3
New cards

The problem in the clinic

Every LFS carrier gets the same surveillance

4
New cards

Total people tested

8,159

5
New cards

P/LP carriers

5,034

6
New cards

Tested negative (the floor)

2,925

7
New cards

Truncating carriers (count)

1,041

8
New cards

Other missense carriers (count)

2,515

9
New cards

R337H carriers (count)

1,080

10
New cards

Truncating variant

Protein cut short: nonsense, frameshift, splice-site or large deletion; no full-length protein

11
New cards

Missense variant

One amino acid swapped for another

12
New cards

R337H

Brazilian founder missense, arginine to histidine at codon 337, in the tetramerization domain (outside DNA-binding)

13
New cards

Reference group for every hazard ratio

Other missense

14
New cards

Why other missense is the reference

Largest (2,515) and most typical group, so the most stable comparison

15
New cards

Methods (one line)

Kaplan-Meier risk curves and Cox hazard ratios vs other missense, clustered by family, rerun with probands removed

16
New cards

Why cluster by family

Relatives share the same variant, so they are not independent

17
New cards

Proband

First person tested in a family, usually because they already had cancer

18
New cards

Probands-removed result

Everything held: a check, not a correction

19
New cards

Kaplan-Meier curve shows

Share who have had that cancer by each age, counted from birth

20
New cards

Hazard ratio means

Rate of the cancer at any given age vs other missense; above 1 more, below 1 less

21
New cards

HR whose interval crosses 1 means

No detectable difference

22
New cards

Breast HR, truncating vs other missense

1.72 (1.45 to 2.03)

23
New cards

First-cancer HR, truncating vs other missense

1.61 (1.41 to 1.84)

24
New cards

Brain HR, truncating vs other missense

1.06 (0.79 to 1.42): no difference

25
New cards

Brain HR, R337H vs other missense

0.32 (0.21 to 0.48): about a third

26
New cards

Breast HR, R337H vs other missense

0.65 (0.55 to 0.77)

27
New cards

First-cancer HR, R337H vs other missense

0.59 (0.52 to 0.66)

28
New cards

Breast risk by 60: truncating vs R337H

79% vs 56%

29
New cards

Brain risk by 60: other missense vs R337H

11% vs 4% (11.3% vs 3.8%)

30
New cards

First LFS cancer risk by 60, truncating

78.2%

31
New cards

Finding 1

Truncating highest for breast and first cancer

32
New cards

Finding 2

R337H lowest in all three outcomes

33
New cards

Finding 3

Brain is the exception: truncating and other missense alike

34
New cards

Why is 79% not a real-world risk

Families get tested after cancer shows up, no delayed entry, no competing risk, so absolute curves run high

35
New cards

What is the real finding

The comparison between groups, not the absolute percentages

36
New cards

Why brain, breast, first cancer

Brain: summer lead (LoF/DN enriched), Amos assigned brain then breast; breast: most common LFS cancer in women; first cancer: overall picture

37
New cards

Sex and brain

Men about twice the brain hazard (HR 2.15); sex-adjusted check did not change the mutation-type result

38
New cards

Functional-class grid question

Which cancer, given cancer: each class vs all other affected carriers

39
New cards

Five functional classes

Loss of function, dominant negative, gain of function, temperature-sensitive, partial function

40
New cards

Grid primary method

Logistic regression with cluster-robust standard errors on family

41
New cards

Grid sensitivity check

One row per family, Fisher's exact test

42
New cards

FDR method

Benjamini-Hochberg; star = q < 0.05

43
New cards

Grid pattern

LoF, DN, GoF lean to brain, sarcoma, leukemia, colorectal; TS and partial lean away; breast flat near 1

44
New cards

Link between grid and R337H

1,081 of 1,338 temperature-sensitive carriers are R337H: both analyses single out R337H

45
New cards

Germline check

Removed families flagged as blood-only (CHIP or blood cancer), not inherited

46
New cards

Software

Python, lifelines package (KaplanMeierFitter, CoxPHFitter)

47
New cards

Limit: one site

765 of 985 R337H carriers in the brain analysis come from one site

48
New cards

Future work 1

Correct for how families were found (Mendel, kin-cohort) with delayed entry and competing risk

49
New cards

Future work 2

Classify variants without a functional call; validate in carriers not found through cancer

50
New cards

So what

Mutation type could guide how closely carriers are watched, once corrected

51
New cards

TAD / PRD / DBD / TET / CTD

Transactivation, proline-rich, DNA-binding, tetramerization, C-terminal domains